retatrutide clinical trials news ESC 2024: improves lipid and cardiovascular risk profile in Phase II trial Eli Lilly infiltrates anti-obesity market
Description
It works by stimulating GLP-1 receptors in the brain, which causes the body to feel full after eating smaller portions of food
GLP-1, or glucagon-like peptide-1, is a hormone produced in the intestines in response to food intake
This information is not intended to substitute professional medical advice, diagnosis, or treatment
While the scale might be going down due to fat loss, building or maintaining muscle improves your overall body composition
